Krill oil: evidence of a new source of polyunsaturated fatty acids with high bioavailability

References

• Cicero AF, De Sando V, Parini A, Borghi C. Polyunsaturated fatty acids application in internal medicine: beyond the established cardiovascular effects. Arch. Med. Sci. 8, 784–793 (2012).
   Google Scholar
• Cicero AF, Ertek S, Borghi C. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr. Vasc. Pharmacol. 7, 330–337 (2009).
   Google Scholar
• Cicero AF, Morbini M, Borghi C. Do we need “new” omega 3 polyunsaturated fatty acids formulations? Exp. Opin. Pharmacother. (2015) (In Press).
   Google Scholar
• Ramprasath VR, Eyal I, Zchut S, Jones PJH. Enhanced increase of omega 3 index in healthy individuals with response to 4 week n-3 fatty acid supplementation from krill oil versus fish oil. Lipids Health Dis. 12, 178 (2013).
   Google Scholar
• Naguib YM. Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 48, 1150–1154 (2000).
   Google Scholar
• Ulven SM, Kirkhus B, Lamglait A et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 46, 37–46 (2011).
   Google Scholar
• Bunea R, El Farrah K, Deutsch L. Evaluation of the Effects of neptune krill oil on the clinical course of hyperlipidemia. Alt. Med. Rev. 9, 420–428 (2004).
   Google Scholar
• Berge K, Piscitelli F, Hoem N et al. Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men. Lipids Health Dis. 12, 78 (2013).
   Google Scholar
• Deutsch L. Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. J. Am. Coll. Nutr. 26, 39–48 (2007).
   Google Scholar
• Matias I, Petrosino S, Racioppi A, Capasso R, Izzo AA, Di Marzo V. Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets. Mol. Cell. Endocrinol. 286, S66–S78 (2008).
   Google Scholar
• Annuzzi G, Piscitelli F, Di Marino L et al. Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. Lipids Health Dis. 9, 43 (2010).
   Google Scholar
• Di Marzo V, Cote M, Matias I et al. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia 52, 213–217 (2009).
   Google Scholar
• Sipe JC, Scott TM, Murray S et al. Biomarkers of endocannabinoid system activation in severe obesity. PLoS ONE 5, e8792 (2010).
   Google Scholar
• Banni S, Carta G, Murru E et al. Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutr. Metab. 8, 7 (2011).
   Google Scholar
• Sampalis F, Bunea R, Pelland MF, Kowalski O, Duguet N, Dupuis S. Evaluation of the effects of Neptune Krill Oil™ on the Management of premenstrual syndrome and dysmenorrhea. Alt. Med. Rev. 8, 171–179 (2003).
   Google Scholar
• Konagai C, Yanagimoto K, Hayamizu K, Han L, Tsuji T, Koga Y. Effects of krill oil containing n-3 polyunsaturated fatty acids in phospholipid form on human brain function: a randomized controlled trial in healthy elderly volunteers. Clin. Interv. Aging 8, 1247–1257 (2013).
   Google Scholar
• Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Alt. Med. Rev. 12, 207–227 (2007).
   Google Scholar
• Westerhof W, van Ginkel CJ, Cohen EB, Mekkes JR. Prospective randomized study comparing the debriding effect of krill enzymes and a non-enzymatic treatment in venous leg ulcers. Dermatologica 181, 293–297 (1990).
   Google Scholar
• Ferramosca A, Zara V. A krill oil supplemented diet reduces the activities of the mitochondrial tricarboxylate carrier and of the cytosolic lipogenic enzymes in rats. J. Anim. Physiol. Anim. Nutr. 96, 295–306 (2012).
   Google Scholar
• Ferramosca A, Zara V. Modulation of hepatic steatosis by dietary fatty acids. World J. Gastroenterol. 20, 1746–1755 (2014).
   Google Scholar